Figure 3.
Breast carcinoma, same patient after 0.1 mmol/kg of Magnevist (a) and Multihance (b). The enhancement of the lesion is higher after Multihance, with a better delineation of the borders as well as of spiculated margins.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.